Astrana Health (ASTH) to Release Quarterly Earnings on Thursday

Astrana Health (NASDAQ:ASTH) is projected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $639.13 million for the quarter. Astrana Health has set its Q2 2025 guidance at EPS and its FY 2025 guidance at EPS.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). The company had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company’s quarterly revenue was up 53.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.31 EPS. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astrana Health Trading Up 2.8%

Shares of ASTH stock opened at $24.08 on Thursday. The stock has a market cap of $1.35 billion, a price-to-earnings ratio of 33.44, a PEG ratio of 0.86 and a beta of 0.84. The stock has a 50-day moving average of $24.69 and a 200-day moving average of $29.74. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. Astrana Health has a 1-year low of $22.45 and a 1-year high of $63.20.

Hedge Funds Weigh In On Astrana Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Royal Bank of Canada lifted its holdings in Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after buying an additional 17,028 shares during the period. Intech Investment Management LLC lifted its holdings in Astrana Health by 5.8% in the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after buying an additional 2,462 shares during the period. AQR Capital Management LLC acquired a new position in Astrana Health in the first quarter valued at $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Astrana Health by 5.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after buying an additional 1,263 shares during the period. Finally, Jones Financial Companies Lllp lifted its holdings in Astrana Health by 4,365.2% in the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the period. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.